Biomaxima (BMX) — Capital Reinvestment Ratio
Latest as of September 2025:
0.30x
Biomaxima (BMX) has a Capital Reinvestment Ratio of 0.30x as of September 2025, meaning it reinvests 0% of its operating cash flow (zł1.01 Million) in capital expenditures (zł308.00K). See BMX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.30x
Capex / Operating Cash Flow
Operating Cash Flow
zł1.01 Million
PLN
Capital Expenditures
zł308.00K
PLN
Data as of
Sep 2025
Most recent filing
Biomaxima Capital Reinvestment Ratio (2009–2023)
This chart tracks Biomaxima's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Biomaxima (2009–2023)
Year-by-year Capital Reinvestment Ratio for Biomaxima from 2009 to 2023. For live market cap and broader valuation context, see Biomaxima (BMX) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 11.36x | zł1.59 Million | zł18.08 Million | ▲ +4160.7% |
| 2022 | 0.27x | zł37.06 Million | zł9.88 Million | ▼ -43.7% |
| 2020 | 0.47x | zł3.97 Million | zł1.88 Million | ▲ +42.4% |
| 2019 | 0.33x | zł4.93 Million | zł1.64 Million | ▼ -96.0% |
| 2018 | 8.22x | zł2.12 Million | zł17.42 Million | ▲ +597.5% |
| 2017 | 1.18x | zł1.84 Million | zł2.17 Million | ▲ +350.8% |
| 2016 | 0.26x | zł1.44 Million | zł376.12K | ▲ +270.3% |
| 2015 | 0.07x | zł2.29 Million | zł161.42K | ▼ -73.3% |
| 2014 | 0.26x | zł561.02K | zł148.50K | ▼ -65.6% |
| 2013 | 0.77x | zł1.25 Million | zł961.18K | ▼ -50.2% |
| 2011 | 1.54x | zł1.83 Million | zł2.83 Million | ▼ -93.6% |
| 2010 | 24.11x | zł102.89K | zł2.48 Million | ▲ +678.8% |
| 2009 | 3.10x | zł418.32K | zł1.30 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow